Editorial
Аннотация
Dear colleagues! It has already become a good tradition to devote annually the third issue of our journal to the fundamental and clinical research, and development of surgical approaches to the treatment of non-ischemic heart diseases. This year, we are faced with the global
A single-center experience with magnetically levitated left ventricular assist device for treatment of end-stage heart failure
Аннотация
U se of left ventricular assist devices (LVAD) both as bridge-to-transplant and destination therapy has become a standard of care in advanced heart failure therapy [1]. Technical developments introduced in past decades as well as improvements of patient and adverse
The future of cardiac surgery: minimally invasive VAD implantations
Аннотация
In the last twenty years, left ventricular Assist Devices (LVADs) have evolved from rescue to regular therapy in the treatment of terminal heart failure. In the past, devices were rather bulky and notwithstanding being life saving devices for many, the quality of life
Long-term results as an indicator of fundamental problems in cardiac transplantology
Аннотация
References 1. Barnard Ch.N. The operation. A human cardiac transplant: an interior report of a successful operation performed at Groote Seheur Hospital Cape Town. S Afr Med J. 1967; 41: 1271-4. 2. Demikhov V.P. Vital organ
3-year outcomes with ex-vivo allograft perfusion for heart transplantation: comparison of Custodiol vs warm blood cardioplegia and conditioning
Аннотация
H eart transplantation is an established therapy for patients with end-stage heart failure (HF). Heart transplantation remains the final option only after all measures has not been successful in improving the degree of HF. Due to the growing number of patients
In vitro implantation of the new transcatheter prosthesis in mitral valve position of a silicone 3D heart model
Аннотация
References 1. Bockeria L.A., Gudkova R.G. Cardiovascular surgery - 2015. Diseases and congenital anomalies of the circulatory system. Moscow: NTsSSKh im. A.N. Bakuleva RAMN, 2016: 208 p. (in Russian) 2. Zheleznev S.I.,
Right minithoracotomy as safe and effective approach for surgical treatment of mitral valve dysplasia
Аннотация
References 1. Antunes M.J. Minimally invasive valve surgery: reality, dream or utopia? J Heart Valve Dis. 1988; 7 (4): 358-9. 2. Casselman F.P., Van Slycke S, Dom H., et al. Endoscopic mitral valve repair feasible, reproducible and durable. J Thorac Cardiovasc
Comparative assessment of different surgical treatment methods in obstructive hypertrophic cardiomyopathy
Аннотация
References 1. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014; 35: 2733-79. 2. Maron B.J., Rowin E.J., Udelson J.E., Maron M.S
Myocarditis in right ventricular arrhythmogenic dysplasia/cardiomyopathy: frequency, role in phenotype development, results of treatment
Аннотация
References 1. Protonotarios A., Elliott P.M. Arrhythmogenic cardiomyopathies (ACs): diagnosis, risk stratification and management. Heart. 2019; 105 (14): 1117-28. DOI: https://doi.org/10.1136/heartjnl-2017-311160 2.
Left ventricular non-compaction cardiomyopathy: additional predictors of life-threatening events for selecting patients for cardioverter defibrillator implantation
Аннотация
References 1. Arbustini E., Weidemann F., Hall J. Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol. 2014; 64: 1840-50. DOI: https://doi.org/10.1016/j
Familial case of dilated cardiomyopathy: organ preserving heart remodeling, and etiological diagnosis over the generation
Аннотация
References 1. Blagova O.V., Nedostup A.V., Kogan E.A. Diseases of the myocardium and pericardium: from syndromes to diagnosis and treatment. Moscow: GEOTAR-Media, 2019: 883 p. (in Russian) 2. Vinogradova N.G. City center for the
Acute myocardial damage with CoronoVIrus Disease 2019 (COVID-19) (case study)
Аннотация
References 1. World Health Organization, Coronavirus disease 2019 (COVID-19): situation report, 121. 2020. P. 19. 2. Madjid M., et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA
Obstructive hypertrophic cardiomyopathy in association with chronic exudative pericarditis and COVID-19
Аннотация
References 1. Maron B.J., Maron M.S. A discussion of contemporary nomenclature, diagnosis, imaging, and management of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2016; 118 (12): 1897-907. DOI: https://doi.org/10.1016/j.amjcard.2016
The manifestation of genetic-related cardiomyopathy after myocarditis (a clinical case)
Аннотация
References 1. Federal clinical guidelines for providing medical care to children with myocarditis. Moscow: Soyuz pediatrov Rossii, Assotsiatsiya detskikh kardiologov Rossii, 2015. (in Russian) 2. Pettit M.A., Koyfman A., Foran M. Myocarditis. Pediatr Emerg Care. 2014; 30
A case of early ischemic stroke after LVAD implantation successfully treated with mechanical thrombus extraction
Аннотация
A 32 years old socially and physically active female with no previously known comorbidities has presented to tertiary hospital with shortness of breath at rest, progressive weakness and dry cough. On admission, she was conscious and alert, pale with cool clammy
Left ventricular assist devices (LVADs): clinical applications and outcomes
Аннотация
Continuous flow LVADs: second and third generation LVADs LVAD design evolved radically after the REMATCH trial with the development of continuous flow (CF) LVADs. These were no longer pulsatile. Instead, blood was propelled through a rotor. Flow was continuous and